Fundraising Fox

Michael Aberman

Investor

Partner at SOSV

New York, New York

Writes $100K – $2M checks · typically $1M

Experience

  1. Regeneron VenturesGeneral Partnercurrent2024 — present
  2. XenImmune Therapeutics, Inc.Board Membercurrent2021 — presentNew York, United States
  3. Excision BioTherapeuticsBusiness Advisor2020 — 2024New York, United States
  4. Rover DiagnosticsBoard Member2020 — 2024New York, United States
  5. Unnatural ProductsBoard Member2020 — 2024New York, United States
  6. ImmunaiSeniorAdvisor2020 — 2022New York, United States
  7. Quentis Therapeutics, IncPresident and CEO2017 — 2019New York City Metropolitan Area
  8. Regeneron PharmaceuticalsSenior Vice President, Strategy and Investor Relations2010 — 2017
  9. Credit SuisseBiotech Analyst2006 — 2010
  10. Morgan StanleyBiotech Analyst2004 — 2006
  11. AntigenicsSenior Director, Business Development2002 — 2004
  12. New York Presbyterian HospitalResident1997 — 2000New York City Metropolitan Area

Education

  1. The Wharton SchoolMBA, Healthcare2000 — 2001
  2. University of TorontoMD, Medicine1993 — 1997
  3. Cornell UniversityBA, Biology1989 — 1993

Deals · 1

Tasca TherapeuticsBoard seat

via SOSV · filed Dec 2025 · $70.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at SOSV

Frequently asked questions

Where does Michael Aberman work?
Michael Aberman is Partner at SOSV.
What check size does Michael Aberman write?
Michael Aberman typically writes checks of $100K – $2M.

Same school

Shared employers